Dupilumab‐related ocular surface disorders in a paediatric cohort with atopic dermatitis, treated in a tertiary paediatric hospital in London

• Main Authors: Anjali Rampersad (Author), Karolina Gholam (Author), Lea Solman (Author), Natalia Cartledge (Author), Sri Gore (Author), Gabriela Petrof (Author)
• Format: Book
• Published: Wiley, 2024-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Dupilumab is the first human monoclonal antibody approved for the treatment of moderate-severe atopic dermatitis (AD) in children from 6 years of age. Real‐world studies reviewing dupilumab‐related ocular surface disorders (DROSD) in the paediatric population are needed to detail...